3% of U.S. High School Students Identify as Transgender, First National Survey Finds
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
WEDNESDAY, Oct. 9, 2024 (HealthDay news) -- About 3% of U.S. high school students identify as transgender, according to the first federal attempt to gather national data on trans teens.
Another 2% question their gender identity, results from the 2023 Youth Risk Behavior Survey showed.
The survey also found that trans and gender-questioning teens face much higher rates of bullying, persistent sadness and suicidal thoughts or behaviors compared with their cisgender peers.
For example, bullying occurs twice as frequently among transgender teens compared to cisgender students, data from the U.S. Centers of Disease Control and Prevention revealed.
“We have 5% of young people in the country who, because of the way they identify around their gender, are stigmatized, bullied, made to feel unsafe, feel disconnected at school and consequently have poorer mental health and higher risk for suicide than their cisgender peers,” Kathleen Ethier, director of the CDC’s adolescent and school health division, told the New York Times. “That’s just heartbreaking.”
The 2023 Youth Risk Behavior Survey is the first time the annual survey asked teens whether they identify as transgender or are gender-questioning. The survey included 20,103 public and private school students in grades 9 through 12 from all 50 U.S. states and the District of Columbia.
About 40% of trans and gender-questioning students reported bullying, compared to 20% of cisgender girls and 15% of cisgender boys, survey results showed.
In addition, around 25% of trans and gender-questioning students skipped school within the past 30 days because they felt unsafe, compared with about 8% of cisgender boys and 15% of cisgender girls.
Transgender students also were much more likely to report:
Transgender students often also reported extreme feelings of isolation. About 36% of trans teens and 46% of gender-questioning teens said they feel close to others at school, compared with 51% of cisgender girls and 62% of cisgender boys.
Trans teens also are more likely to experience unstable housing, about 11% compared with around 2% of cisgender boys or girls.
“The structural and interpersonal discrimination, including family rejection, faced by transgender students puts this population at increased risk for experiencing unstable housing,” the researchers said in their report, published Oct. 10 in the CDC publication Morbidity and Mortality Weekly Report. “Transgender students might experience discrimination, harassment and assault among foster, shelter and other social service providers that make this population less likely to be sheltered when experiencing unstable housing, compounding their vulnerability to experiences of violence, poor mental health and suicidal thoughts and behaviors.”
The CDC report called on educators to help trans and gender-questioning teenagers -- and, by extension, all teens -- by offering troubled students a safe haven.
“Schools are in a unique position to create safe and supportive environments, free from violence and bullying, for all students, including transgender and questioning students,” the report noted.
“In particular, school connectedness and activities to promote safe and supportive environments are associated with decreased odds of experiencing violence, poor mental health and suicidal thoughts and behaviors among high school students,” the report added. “Activities that are inclusive of LGBTQ+ students are associated with decreases in the odds of these experiences among all students, regardless of sexual identity.”
If you or a loved one are experiencing a suicidal crisis or emotional distress, call or text 988 to reach the 988 Suicide and Crisis Lifeline.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-09 06:00
Read more
- Heat Waves Linked to Adverse Health Outcomes for Seniors
- Study Assesses Risk for 28-Day Hospitalization for Adults With RSV
- Incidence of Dyslipidemia Elevated During COVID-19 Pandemic
- Shorla Oncology Announces U.S. FDA Expanded Approval of Jylamvo (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications
- 1 in 4 Moms Fall Asleep While Breastfeeding, Putting Babies at Risk for SIDS
- Can AI Boost Accuracy of Doctors' Diagnoses?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions